Search results for " cell therapy"

Article Bioterminology: A Guide to the Biopharmaceutical Lexicon
Bioterminology: A Guide to the Biopharmaceutical Lexicon This lexicon was generated by the editors of BioPharm International magazine. Please feel free to email your suggestions for terms that s…

Article New Therapies Present Scaling Challenges
With a cell therapy, however, establishing cost-effective ways to commercially manufacture cell therapies for mainstream use remains a challenge. For a gene therapy, some aspects of its manufacturing …

Article Patenting Prospects for Cell-Based Therapies
For example, the NurOwn cell therapy product (Brainstorm Cell Therapeutics, Inc.) is comprised of autologous mesenchymal stem cells (MSCs) modified to express neurotrophic factors, shown to promote mo…

Article Downstream Processing for Cell-Based Therapies
By Qasim A. Rafiq, Fernanda Masri With increasing numbers of advanced therapies—including cell and gene therapies—entering early- and late-stage clinical development, significant focus has been …

Article Science Focus Fuels Successful Process Development for Startups
…y developing cell therapies for immuno-oncology and autoimmune indications using its proprietary SQZ cell therapy platform, also known as cell squeezing. “There are no established protocols for how t…

Article FDA Framework Spurs Advanced Therapies
Greater clarity on the application of existing regulations will accelerate development of cell and gene therapies. By Cynthia A. Challener Ibreakstock/Shutterstock.co…

Article Emerging Therapies Test Existing Bioanalytical Methods
The technology allows for real-time monitoring of the cell therapy in vivo and can support the qPCR data for PK. Flow panels can be designed to evaluate the expression and persistence of the construct…

Article Improving Upstream Predictability
Better understanding and control of cell behavior is yielding benefits, upstream and beyond. By Agnes Shanley In the earliest days of biotech, developers often struggled to sustain …

Article Manufacturing Standards Key to Advancing Cellular and Gene Therapies
  Bryan Silvey, senior director for quality compliance at Kite Pharma, emphasized that personalized cell therapy production, utilizing a “one lot-one patient” manufacturing platform with a 15-d…

Article Scaling Up Novel Therapies
However, with novel products such as cell therapy, the costs of production can be so high (e.g., including the cost of reagents for cell adherence and culture), that the whole process itself is essent…

Previous PageNext Page